Shares of Catalyst Pharmaceuticals rose 3.02% to $3.74 at 09:59 EST on Monday, following yesterday’s upward trend. The Nasdaq Stock Market is falling 0.23% to $12,377.90, following yesterday’s downward trend, This seems, at the moment, a somewhat rough trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.61, 41.20% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the current quarter and 4.6% for the next. The company’s growth estimates for the current quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.74 at 09:59 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way above its 50-day moving average of $3.35 and below its 200-day moving average of $3.80.

LEAVE A REPLY

Please enter your comment!
Please enter your name here